PharmaTutor (March- 2014)
ISSN: 2347 - 7881
Received On: 03/02/2014; Accepted On: 09/02/2014; Published On: 05/03/2014
Author:
Hemant Maheta, MR Patel, KR Patel, MS Patel
Department of Pharmaceutics,
Shri B.M.Shah College of Pharmaceutical Education and Research,
College Campus, Modasa-383315, Gujarat, India.
hsmehta19@gmail.com
ABSTRACT:
The purpose of writing this review on floating drug delivery systems was special focus on the principle mechanism of floatation to achieve gastric retention. Conventional oral dosage forms has short residence times & unpredictable gastric emptying time. The idea of gastric retention comes from the need to localize drugs at a specific region of gastrointestinal tract (GIT) such as stomach in the body. Many drugs get absorbed only in the upper intestinal tract, designing such molecules as once-daily formulations are exclusive for these molecules. Thus GI retention platforms had emerged. Gastroretentive drug delivery systems are designed to be retained in the stomach for a prolonged time. Gastroretentive drug delivery systems have potential for use as controlled release drug delivery system. The use of floating drug delivery system is one method to achieve prolonged gastric residence times, providing opportunity for both local & systemic drug action. Thus, gastroretention could help to provide greater availability of new products and consequently improved therapeutic activity and substantial benefits to patients. This article aims at reviewing the floating drug delivery system including types, approaches for designing the floating dosage form, advantages & disadvantages of FDDS.
How to cite this article: H Maheta, MR Patel, KR Patel, MS Patel, Review: An Overview on Floating Drug Delivery System, PharmaTutor, 2014, 2(3), 61-71
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1. Arora S, Ahuja A. Floating drug delivery system: A Review. J. AAPS Pharm Sci Tech 2005; Vol.6 (03): 372-390.
2. Deshpande AA, Rhodes CT, Shah NH, Malick AW. Controlled-release drug delivery systems for prolonged gastric residence: An overview. Drug Dev and Ind Pharm 1996; 22:631-9.
3. Hwang SJ, Park H, Park K. Gastric retentive drug-delivery systems. Crit Rev Ther Drug Carrier Syst 1998; 15:243-83.
4. Degen LP, Peng F, Collet A, Rossi L, Ketterer S, Serrano Y, et al. Blockade of GRP receptors inhibits gastric emptying and gallbladder contraction but accelerates small intestinal transit. Gastroenterology 2001; 120:361-8.
5. Kydoneius A. Controlled Release Technologies. 2nd Ed. New York: Marcel Dekker; 1991; 24-109.
6. Petrakis IE, Kogerakis N, Vrachassotakis N, Stiakakis I, Zacharioudakis G, Chalkiadakis G. Hyperglycemia attenuate erythromycin-induced acceleration of solidphase gastric emptying in healthy subjects. Abdom Imaging 2002; 27:309- 14.
7. Silang R, Regalado M, Cheng TH, Wesson DE. Prokinetic agents increase plasma albumin in hypoalbuminemic chronic dialysis patients with delayed gastric emptying. J Kidney Dis 2001; 37:287- 93.
8. Garg S and Sharma S. Gastroretentive Drug Delivery System, Business Briefing: Pharmatech. 2003;160-166
9. Timmermans J, Mo?s AJ, “How well do floating dosage forms float?’’ Int. J. Pharmaceutics.1990, 62, 207-216.
10. Yang L and Fassihi R. Zero order release kinetics from self correcting floatable configuration drug delivery system. J Pharm Sci. 1996; 85:170- 173.
11. Burns SJ, Attwood D and Barnwell SG. Assesment of a dissolution vessel designed for use with floating and erodible dosage forms. Int J Pharm. 1998; 160:213-218.
12. Joseph NJ, Laxmi S and Jayakrishnan A. A floating type oral dosage form for piroxicam based on hollow microspheres: in vitro and in vivo evaluation in rabbits. J Control Release. 2002; 79:71-79.
13. Sheth PR and Tossounian JL. Inventors. Sustained release pharmaceutical capsules. US patent. 1978; 4:126-672.
14. Soppimath KS, Kulkarni AR, Rudzinski WE and Aminabhavi TM. Microspheres as floating drug delivery system to increase the gastric residence of drugs. Drug Metab Rev. 2001; 33:149-160.
15. Ichikawa M, Watanabe S and Miyake Y. A new multiple unit oral floating dosage system. I: Prepration and in vitro evaluation of floating and sustained-release kinetics. J Pharm Sci. 1991; 80:1062-1066.
16. Chawla G, Gupta P, Koradia V and Bansal AK. Gastroretention: A Means to Address Regional Variability in intestinal drug Absorption, Pharmaceutical technology. 2003; 27(2):50-68.
17. Chandel A, Chauhan K, Parashar B, Kumar H and Arora S Floating drug delivery systems: A better approach. International Current Pharmaceutical Journal. 2012; 1(5):110-118.
18. Rubinstein A and Friend DR. Specific delivery to the gastrointestinal tract, in: A. J. Domb (Ed.), Polymeric sitespecific Pharmacotherapy, Wiley, Chichester. 1994; 282-283.
19. Vyas SP and Roop KK. Controlled Drug Delivery Concepts and Advances, First Edition, New Delhi. 2002; 196- 217.
20. Jain NK. Progress in Controlled and Novel Drug Delivery Systems. First Ed. CBSS. Gopalakrishnan. Journal of Pharmaceutical Science and Technology. Publishers and Distributors, New Delhi, Bangalore. 2004; 3(2):84-85.
21. Goyal M, Prajapati R, Purohit KK and Mehta SC. Floating drug delivery system, Journal of current pharmaceutical research. 2011; 5(1): 7-18.
22. Klausner EA, Sara E, Lavy E, Friedman M and Hoffman A. Novel levodopa gastro-retentive dosage form: in-vivo evaluation in dogs. J. Control. Release. 2003; 88:117-126.
23. Kale RD and Tayade PT. A multiple unit floating drug delivery system of Piroxicam using Eudragit polymer. Indian J PharmScie. 2007; 69(1):120- 123.
24. Sangekar S. Evaluation of effect of food and specific gravity of the tablets on gastric retention time. Int J Pharm. 1987; 35(3):34-53.
25. Moursy NM, Afifi NH, Ghorab DM and El-Saharty Y. Formulation and evaluation of sustained release floating capsules of Nicardipine hydrochloride. Pharmazie. 2003; 58: 38-43.
26. Kamalakkannan V, Pyratchikody A, Viswanadhan VP, “Enhancement of Drugs bioavailability by Floating Drug Delivery System-A Review.’’ Int. J. Drug Delivery.2011, 3(4), 558-570.
27. Geetha A, Rajendrakumar J. A Review on floating drug delivery system. Int. J. Pharmaceutical Research & Biomedical Analysis, 2012, 1(1), 1-13.
.png)
